Persistence of IPV Immunity

PHASE4CompletedINTERVENTIONAL
Enrollment

502

Participants

Timeline

Start Date

November 21, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

July 30, 2019

Conditions
Poliomyelitis
Interventions
BIOLOGICAL

Inactivated Polio Vaccine (IPV)

Children receive one or two doses of IPV based on study arm they fall in

Trial Locations (3)

Unknown

Kanti Children's Hospital, Kathmandu

Patan Hospital, Kathmandu

Tribhuvan University Teaching Hospital, Kathmandu

All Listed Sponsors
collaborator

World Health Organization

OTHER

collaborator

Centers for Disease Control and Prevention

FED

lead

Tribhuvan University Teaching Hospital, Institute Of Medicine.

OTHER

NCT03723837 - Persistence of IPV Immunity | Biotech Hunter | Biotech Hunter